Evidence map›Paper›PMID 29695882›Full record

ArticleBulletin of the World Health Organization2018

Prevention of mother-to-child transmission of HIV: a cross-sectional study in Malawi.

M van Lettow, M Landes, J J van Oosterhout, E Schouten, H Phiri, E Nkhoma, T Kalua, S Gupta, N Wadonda, A Jahn and 1 more

Abstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

M van LettowDignitas International, PO Box 1071, Zomba, Malawi.
M LandesDepartment of Family and Community Medicine, University of Toronto, Toronto, Canada.
J J van OosterhoutDignitas International, PO Box 1071, Zomba, Malawi.
E SchoutenManagement Sciences for Health, Lilongwe, Malawi.
H PhiriManagement Sciences for Health, Lilongwe, Malawi.
E NkhomaManagement Sciences for Health, Lilongwe, Malawi.
T KaluaDepartment of HIV and AIDS, Ministry of Health, Lilongwe, Malawi.
S GuptaDepartment of HIV and AIDS, Ministry of Health, Lilongwe, Malawi.
N WadondaUnited States Centers for Disease Control and Prevention - Lilongwe, Lilongwe, Malawi.
A JahnDepartment of HIV and AIDS, Ministry of Health, Lilongwe, Malawi.
B Tippett-BarrUnited States Centers for Disease Control and Prevention - Zimbabwe, Harare, Zimbabwe.

Funding

CGH CDC HHS U2G GH000721
6 · The paper itself

Abstract

objectiveTo estimate the use and outcomes of the Malawian programme for the prevention of mother-to-child transmission (MTCT) of human immunodeficiency virus (HIV).

methodsIn a cross-sectional analysis of 33 744 mother-infant pairs, we estimated the weighted proportions of mothers who had received antenatal HIV testing and/or maternal antiretroviral therapy and infants who had received nevirapine prophylaxis and/or HIV testing. We calculated the ratios of MTCT at 4-26 weeks postpartum for subgroups that had missed none or at least one of these four steps.

findingsThe estimated uptake of antenatal testing was 97.8%; while maternal antiretroviral therapy was 96.3%; infant prophylaxis was 92.3%; and infant HIV testing was 53.2%. Estimated ratios of MTCT were 4.7% overall and 7.7% for the pairs that had missed maternal antiretroviral therapy, 10.7% for missing both maternal antiretroviral therapy and infant prophylaxis and 11.4% for missing maternal antiretroviral therapy, infant prophylaxis and infant testing. Women younger than 19 years were more likely to have missed HIV testing (adjusted odds ratio, aOR: 4.9; 95% confidence interval, CI: 2.3-10.6) and infant prophylaxis (aOR: 6.9; 95% CI: 1.2-38.9) than older women. Women who had never started maternal antiretroviral therapy were more likely to have missed infant prophylaxis (aOR: 15.4; 95% CI: 7.2-32.9) and infant testing (aOR: 13.7; 95% CI: 4.2-83.3) than women who had.

conclusionMost women used the Malawian programme for the prevention of MTCT. The risk of MTCT increased if any of the main steps in the programme were missed.

Indexed as

Anti-HIV AgentsChemopreventionChildChild, PreschoolCross-Sectional StudiesFemaleHIV InfectionsHumansInfantInfectious Disease Transmission, VerticalMalawiPregnancyPregnancy Complications, InfectiousAnti-HIV Agents

Identifiers

PMID29695882
PMCPMC5872011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.